We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
RSS Email Alerts
Please Wait... Processing your request... Please Wait.

JAMA Clinical Challenge | 
Yuanquan Yang, MD, PhD; Missak Haigentz Jr, MD; Mary Welch, MD
JAMA. 2015;314(9):942-943. doi:10.1001/jama.2015.8617.

News From the Food and Drug Administration | 
Rebecca Voelker, MSJ
JAMA. 2015;314(7):662. doi:10.1001/jama.2015.9768.

JAMA Clinical Evidence Synopsis | 
Mia Schmidt-Hansen, BSc, PhD; David Raymond Baldwin, MD, FRCP; Javier Zamora, BSc, MSc, PhD
JAMA. 2015;313(14):1465-1466. doi:10.1001/jama.2015.2365.

Health Agencies Update | 
Tracy Hampton, PhD
JAMA. 2015;313(12):1199. doi:10.1001/jama.2015.1655.

Research Letter |  FREE
Yi Wang, MD; David E. Midthun, MD; Jason A. Wampfler, BS; et al.
JAMA. 2015;313(8):853-855. doi:10.1001/jama.2015.413.

From the JAMA Network | 
Russell P. Harris, MD, MPH
JAMA. 2015;313(7):717-718. doi:10.1001/jama.2014.14769.

The JAMA Forum |  FREE
Andrew Bindman, MD
JAMA. 2015;313(1):17-18. doi:10.1001/jama.2014.16429.

Editorial | 
Harold C. Sox, MD
JAMA. 2014;312(12):1206-1207. doi:10.1001/jama.2014.12921.

JAMA Clinical Guidelines Synopsis | 
Andrew M. Davis, MD, MPH; Adam S. Cifu, MD
JAMA. 2014;312(12):1248-1249. doi:10.1001/jama.2014.12272.

Original Investigation |  FREE
Stephen A. Deppen, PhD; Jeffrey D. Blume, PhD; Clark D. Kensinger, MD; et al.
JAMA. 2014;312(12):1227-1236. doi:10.1001/jama.2014.11488.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Oncology
Viewpoint  | 
The Slippery Slope of Broadening Treatment Eligibility and Weak End Points Defending the Oligo in Oligometastatic Non–Small-Cell Lung Cancer
Howard (Jack) West, MD
JAMA Internal Medicine
Research Letter  | 
A Randomized Trial Testing US Food and Drug Administration “Breakthrough” Language
Tamar Krishnamurti, PhD; Steven Woloshin, MD, MS; Lisa M. Schwartz, MD, MS; et al.
JAMA Oncology
Review  | 
Hospitalizations During Systemic Therapy for Metastatic Lung Cancer A Systematic Review of Real World vs Clinical Trial Outcomes
Rebecca M. Prince, MBBS, FRACP; Eshetu G. Atenafu, MSc, PStat; Monika K. Krzyzanowska, MD, MPH, FRCPC
JAMA Internal Medicine
Invited Commentary  | 
Tobacco Cessation—We Can Do Better
Michael K. Ong, MD, PhD